Transcatheter Interventions Online - Recent Trials & Future Technologies: Trials

In this session, 'Transcatheter Interventions Online 2020 - Recent Trials and Future Technology: Trials' leading experts present insights and discuss the latest from the ISCHEMIA Trial, recent TAVI data, and pharmacology for acute and stable coronary syndromes. 

Transcatheter Interventions Online 2020, aims to educate interventionalists and allied healthcare professionals on the practical implications of the latest clinical data, device selection, and procedural strategies impacting optimum patient care. To further illustrate this, the event will feature a number of practical demonstrations in the form of live cases broadcast from cardiovascular centers of excellence globally, interspersed with presentations and debate sessions.

Target Audience

This programme is intended to educate:

Cardiologists, interventionalists and surgeons who are involved and/or interested in transcatheter treatment strategies for coronary and structural heart disease.

Learning Objectives

The overall programme, Transcatheter Interventions Online 2020, endeavours to best address the following learning objectives:

  • Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
  • Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
  • Assess the merits of adopting emerging technologies within their practice
  • Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
  • Interact with opinion leaders in their profession

DISCLOSURES

In compliance with EBAC / EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.

The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

This programme is supported by unrestricted educational grants from the following companies. The scientific programme has not been influenced in any way by the sponsors.

  • Abbott
  • Abiomed
  • Boston Scientific
  • Edwards Lifesciences
  • Medtronic
  • Siemens Healthineers

R-CME DISCLAIMER / TERMS & CONDITIONS

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

This session ‘Transcatheter Interventions Online 2020 - Recent Trials and Future Technology: Trials’ is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credits.

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

INSTRUCTIONS TO PARTICIPANTS

There is no fee for taking part in this online learning activity.

Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

To complete the course and claim certification participants must:

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.
Course summary
Available credit: 
  • 1.00 European Board for Accreditation in Cardiology (EBAC)
Course opens: 
11/04/2020
Course expires: 
07/21/2025
Cost:
£0.00
Rating: 
0

1. ISCHEMIA practical perspectives – Ajay Kirtane
2. Latest in pharmacology: acute and stable coronary syndromes – Roxana Mehran
3. Recent TAVI data - Lars Sondergaard

 

 

 

 

 

SESSION CHAIRS: Dr Roxana Mehran, Mount Sinai Hospital, US; Prof Holger Thiele, Heart Center Leipzig, Germany
SESSION PANEL: Ajay Kirtane, Columbia Medical Center, US; Prof Lars Sondergaard, University of Copenhagen, Denmark; Dr Kendra Grubb, Emory Medical Center, US; Prof David Hildick-Smith, Brighton and Sussex NHS Trust, UK

Available Credit

  • 1.00 European Board for Accreditation in Cardiology (EBAC)

Price

Cost:
£0.00
Please login or register to take this course.